PROCEPT BioRobotics Corporation Share-based Payment Arrangement, Amount Capitalized
PROCEPT BioRobotics Corporation (PRCT) reported Share-based Payment Arrangement, Amount Capitalized of $1.55 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement
us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount · last filed 2026-08-05
- PROCEPT BioRobotics Corporation share-based payment arrangement, amount capitalized for the quarter ending 2026-06-30 was $1.55M, a 36.09% increase year-over-year.
- PROCEPT BioRobotics Corporation share-based payment arrangement, amount capitalized for the quarter ending 2026-03-31 was $1.45M, a 23.27% increase year-over-year.
- PROCEPT BioRobotics Corporation share-based payment arrangement, amount capitalized for the quarter ending 2025-12-31 was $1.35M, a 25.51% increase year-over-year.
- PROCEPT BioRobotics Corporation share-based payment arrangement, amount capitalized for the quarter ending 2025-09-30 was $1.26M, a 20.04% increase year-over-year.
- PROCEPT BioRobotics Corporation share-based payment arrangement, amount capitalized for fiscal 2025 was $4.92M, a 25.86% increase from fiscal 2024.
- PROCEPT BioRobotics Corporation share-based payment arrangement, amount capitalized for fiscal 2024 was $3.91M, a 52.85% increase from fiscal 2023.
- PROCEPT BioRobotics Corporation share-based payment arrangement, amount capitalized for fiscal 2023 was $2.56M, a 668.17% increase from fiscal 2022.
- PROCEPT BioRobotics Corporation share-based payment arrangement, amount capitalized for fiscal 2022 was $333.00K.
| Period end | Share-based Payment Arrangement, Amount Capitalized 3 month | Share-based Payment Arrangement, Amount Capitalized 6 month | Share-based Payment Arrangement, Amount Capitalized 9 month | Share-based Payment Arrangement, Amount Capitalized 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.55M 10-Q · filed 2026-08-05 | $2.99M 10-Q · filed 2026-08-05 | $4.34M derived: sum of 3 quarters · filed 2026-08-05 | $5.60M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $1.45M 10-Q · filed 2026-04-30 | $2.80M derived: sum of 2 quarters · filed 2026-04-30 | $4.06M derived: sum of 3 quarters · filed 2026-04-30 | $5.19M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $1.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.61M derived: sum of 2 quarters · filed 2026-02-26 | $3.75M derived: sum of 3 quarters · filed 2026-08-05 | $4.92M 10-K · filed 2026-02-26 |
| 2025-09-30 | $1.26M 10-Q · filed 2025-11-05 | $2.39M derived: sum of 2 quarters · filed 2026-08-05 | $3.57M 10-Q · filed 2025-11-05 | $4.64M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $1.14M 10-Q · filed 2026-08-05 | $2.31M 10-Q · filed 2026-08-05 | $3.39M derived: sum of 3 quarters · filed 2026-08-05 | $4.43M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $1.17M 10-Q · filed 2026-04-30 | $2.25M derived: sum of 2 quarters · filed 2026-04-30 | $3.30M derived: sum of 3 quarters · filed 2026-04-30 | $4.24M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.13M derived: sum of 2 quarters · filed 2026-02-26 | $3.06M derived: sum of 3 quarters · filed 2026-02-26 | $3.91M 10-K · filed 2026-02-26 |
| 2024-09-30 | $1.05M 10-Q · filed 2025-11-05 | $1.99M derived: sum of 2 quarters · filed 2025-11-05 | $2.83M 10-Q · filed 2025-11-05 | $3.80M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $937.00K 10-Q · filed 2025-08-07 | $1.78M 10-Q · filed 2025-08-07 | $2.75M derived: sum of 3 quarters · filed 2026-02-26 | $3.38M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $847.00K 10-Q · filed 2025-05-02 | $1.81M derived: sum of 2 quarters · filed 2026-02-26 | $2.44M derived: sum of 3 quarters · filed 2026-02-26 | $2.99M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $966.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.60M derived: sum of 2 quarters · filed 2026-02-26 | $2.15M derived: sum of 3 quarters · filed 2026-02-26 | $2.56M 10-K · filed 2026-02-26 |
| 2023-09-30 | $631.00K 10-Q · filed 2024-10-28 | $1.18M derived: sum of 2 quarters · filed 2024-10-28 | $1.59M 10-Q · filed 2024-10-28 | |
| 2023-06-30 | $548.00K 10-Q · filed 2024-08-02 | $962.00K 10-Q · filed 2024-08-02 | ||
| 2022-12-31 | $333.00K 10-K · filed 2025-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |